Navigation Links
Mobidiag Releases First Microarray Based Rapid Test for Herpesvirus Identification
Date:3/12/2008

Prove-it Herpes Offers Considerable Cost Savings for Healthcare Industry by

Identifying Eight Herpesviruses Simultaneously

HELSINKI, Finland, March 12 /PRNewswire/ -- The Finland-based biotechnology company Mobidiag today announced the new Prove-it(TM) Herpes test for the fast and reliable identification of herpesviruses. The microarray-based test takes less than three hours to complete and enables simultaneous identification of eight different human herpesviruses. Herpesviruses cause life-threatening central nervous system infections (CNSI), and rapid diagnosis improves likelihood of recovery. The new test is initially intended for research purposes, and Mobidiag plans to acquire European approval for use in clinical diagnostics later this year.

"Market potential for the product is enormous. In Europe alone, over 100 million euros are spent annually on herpesvirus diagnostics. We believe that Prove-it(TM) Herpes will gain a considerable slice of that market," says Jaakko Pellosniemi, CEO of Mobidiag. "What makes Prove-it(TM) Herpes unique is that it combines different technologies and integrates them into a single easy-to-use and capable product," Pellosniemi continues.

In addition to illnesses such as labial herpes, chickenpox and roseola, herpesviruses can also cause serious central nervous system infections such as encephalitis. Without appropriate treatment, mortality rate from these infections can be as high as 50%. The sooner the pathogen is detected, the higher the likelihood of recovery. However, virus detection may be slow with current methods, and in severe suspected virus infection cases, medication is often started merely as a precaution. There are roughly four million of these suspected cases annually in the Industrial World, making testing and treating potential infections very expensive.

The Mobidiag test can detect and identify the viruses many times faster than conventional methods. Appropriate antivi
'/>"/>

SOURCE Mobidiag Ltd
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Beckman Coulter Releases the High-Volume UniCel(R) DxC 880i Integrated Work Cell
2. BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services
3. MIGENIX releases CEO message #22
4. National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights
5. CellCyte Genetics Corp. Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases
6. Intrasphere Technologies Releases PharmaCM Submissions Management and Authoring Module Powered by Microsoft Office SharePoint Server 2007
7. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
8. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
9. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
10. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
11. Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... (Nasdaq: DNDN ) announced today that the ... exercised in full their option to purchase an ... public offering price of $24.75 per share. ... of the offering to an aggregate of 17,250,000 ... receive net proceeds from the offering of approximately ...
(Date:12/11/2009)... 11 Ambit Biosciences Corporation announced today the ... D. Anderson Cancer Center of the first patient in ... E fficacy) Phase 2 pivotal trial in ... AC220 is a novel, orally available, potent and ... a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ACE ...
(Date:12/11/2009)... 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... the appointment of Dr. Alan Warrander to the ... Business Development. ,, "Dr. Warrander will be responsible ... for REOLYSIN(R)," said Dr. Brad Thompson, President and ... the design of a Phase 3 trial examining ...
(Date:12/10/2009)... Calif., Dec. 10 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today that Dan Lemaitre, ... the Endologix Board of Directors effective December 11, ... and three non-independent directors. ,, Franklin D. Brown, ... to welcome Dan Lemaitre to the Endologix Board ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2
... increased 40.8% to $11.6 million ... Net Income increased 118.8% to $2.5 ... China Medicine,Corporation (OTC Bulletin Board: CHME) ("China Medicine" ... prescription and over-the-counter,pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional ...
... Tate & Lyle Bio Products today announced that its breakthrough ... a natural ingredient by ECOCERT®, one of the leading international ... ... Loudon, TN August 13, 2008 –- http://www.duponttateandlyle.com/ [DuPont ...
... from the Defense Threat Reduction Agency Will Fund the, Advanced Development ... ... Countermeasure -, CHICAGO, Aug. 13 Advanced Life Sciences,Holdings, ... Agency (DTRA) of the U.S. Department of Defense has awarded the,Company ...
Other Biology Technology:China Medicine Announces Strong Second Quarter 2008 Results 2China Medicine Announces Strong Second Quarter 2008 Results 3China Medicine Announces Strong Second Quarter 2008 Results 4China Medicine Announces Strong Second Quarter 2008 Results 5China Medicine Announces Strong Second Quarter 2008 Results 6China Medicine Announces Strong Second Quarter 2008 Results 7China Medicine Announces Strong Second Quarter 2008 Results 8China Medicine Announces Strong Second Quarter 2008 Results 9China Medicine Announces Strong Second Quarter 2008 Results 10China Medicine Announces Strong Second Quarter 2008 Results 11Zemea Propanediol Approved as a Natural Ingredient by ECOCERT 2Zemea Propanediol Approved as a Natural Ingredient by ECOCERT 3Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million 2Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million 3Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million 4
(Date:12/14/2009)... be transmitted by sneezing, touching, or for Tasmanian ... habit that may have driven the dinosaurs to extinction ... Upcroft, a member of f1000 Biology, highlights the ,paleobiological ... PLoS One. This led them to deduce that a ... bones seen in many tyrannosaurid fossils. , The parasite,s ...
(Date:12/14/2009)... defining feature of humans. That,s until examples of tool use ... array of other mammals. Now, a report in the December ... publication, adds an octopus to the growing list of tool ... trick that the researchers call stilt walking. In it, the ... makes its eight arms rigid, and raises the whole assembly ...
(Date:12/13/2009)... about how a popular class of drugs used ... previously hidden components of chemical communication in the ... the illness, people with schizophrenia also struggle to ... order, difficulties that interfere with their ability to ... Schroeder, a student in the medical scientist training ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2NYU Langone Medical Center awarded NIH grants totaling 241 560 000 8981 1NYU Langone Medical Center awarded NIH grants totaling 241 560 000 8981 2NYU Langone Medical Center awarded NIH grants totaling 241 560 000 8981 3Give an Hour 28TM 29s Volunteer Mental Health Professionals Provide More Than 241 4 Million in Services to Iraq and Afghanistan Veterans Families a 49927 1Give an Hour 28TM 29s Volunteer Mental Health Professionals Provide More Than 241 4 Million in Services to Iraq and Afghanistan Veterans Families a 49927 2Give an Hour 28TM 29s Volunteer Mental Health Professionals Provide More Than 241 4 Million in Services to Iraq and Afghanistan Veterans Families a 49927 3PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 1PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 2
... new antimicrobial approach can kill bacteria in laboratory experiments ... a key bacterial nutrient, according to research led by ... at the UW, the University of Iowa, and the ... 2 issue of the Journal of Clinical Investigation. ...
... bacterial composition of the oral cavity even in low doses. ... needed to counteract the production of acid between the teeth, ... defend at Umeå University in Sweden on February 23. , ... of the sugar xylose, or wood sugar. Xylitol occurs ...
... light are providing insight into the complexities of the sense ... how the human brain works. , Investigators at Duke University ... a strain of mice whose olfactory brain cells "fire" when ... cells a gene naturally present in green algae that "turns ...
Other Biology News:Trojan horse strategy defeats drug-resistant bacteria 2Xylitol reduces risk of cavities 2Common algae helps illustrate mammalian brain electrical circuitry 2Common algae helps illustrate mammalian brain electrical circuitry 3
Rabbit anti-T-box 6...
TNF-R2 (L-20)...
Assay Kit formatted for flow cytometric detection of levels of phosphorylated histone H2A.X....
... SizeSep 400 Spun Columns, 10. *SizeSep ... cDNAs > 400 base pairs in length. ... Sepharose CL-4B and pre-equilibrated in distilled water containing ... smaller than ~ 400 base pairs. ...
Biology Products: